Skip to content
DataLookout
Menu

NCT07941986

Association Between Maternal Intrapartum Pethidine Exposure and Respiratory Depression in Late-Preterm Newborns

StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Incidence of Clinically Significant Neonatal Respiratory Depression Within 24 Hours After Birth
Timeframe: From birth through the first 24 hours of life

Secondary (15)

Neonatal Resuscitation at Birth
Need for Neonatal Respiratory Support
Association Between the Pethidine-to-Delivery Interval and Neonatal Respiratory Depression
Apgar Scores
Neonatal Blood pH
Show 10 moreShow less
Neonatal Partial Pressure of Carbon Dioxide (PaCO₂)
Neonatal Partial Pressure of Oxygen (PaO₂)
Neonatal Bicarbonate Concentration (HCO₃-)
Neonatal Blood Lactate Concentration
Neonatal Lung Ultrasound Score
Neonatal Feeding Difficulties
Neonatal Intensive Care Unit (NICU) Admission
Maternal Pain Intensity During Labour
Duration of Active Labour and Labour Progression
Maternal Adverse Effects Associated With Intrapartum Pethidine Exposure

Arms and interventions

Late-Preterm Newborns Exposed to Maternal Intrapartum Pethidine

160 late-preterm newborns (34+0 to 36+6 weeks of gestation) born to mothers who received intrapartum pethidine (meperidine), administered as part of routine clinical care at a planned dose of 50 mg administered via intramuscular (IM) or intravenous (IV) injection alongside combined spinal-epidural analgesia using bupivacaine and fentanyl, administered via the intrathecal and epidural route according to the institutional anesthesia protocol and individual clinical requirements.

Late-Preterm Newborns Without Maternal Intrapartum Pethidine Exposure

160 late-preterm newborns (34+0 to 36+6 weeks of gestation) born to mothers who received combined spinal-epidural (CSE) analgesia using bupivacaine and fentanyl, administered via the intrathecal and epidural route according to the institutional anesthesia protocol and individual clinical requirements without intrapartum pethidine exposure.

Drugs: pethidine hydrochloride